ahlam1399
09-04-2015, 10:27 AM
India?s Cipla says to buy two U.S. generics firms for $550 mln
MUMBAI, Sept 4 (Reuters) - Cipla Ltd, India's fourth-largest drugmaker by sales, said on Friday it has agreed to buy two generics businesses in the United States in an all-cash deal worth $550 million to get access to a wide range of products.
http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/498f2560/sc/28/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=_NqOty3M3A0:gDoNkqmftMo:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=_NqOty3M3A0:gDoNkqmftMo:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=_NqOty3M3A0:gDoNkqmftMo:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=_NqOty3M3A0:gDoNkqmftMo:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=_NqOty3M3A0:gDoNkqmftMo:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/_NqOty3M3A0
MUMBAI, Sept 4 (Reuters) - Cipla Ltd, India's fourth-largest drugmaker by sales, said on Friday it has agreed to buy two generics businesses in the United States in an all-cash deal worth $550 million to get access to a wide range of products.
http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/498f2560/sc/28/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=_NqOty3M3A0:gDoNkqmftMo:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=_NqOty3M3A0:gDoNkqmftMo:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=_NqOty3M3A0:gDoNkqmftMo:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=_NqOty3M3A0:gDoNkqmftMo:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=_NqOty3M3A0:gDoNkqmftMo:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/_NqOty3M3A0